Home/Filings/4/0001209191-22-004415
4//SEC Filing

Barton Russell 4

Accession 0001209191-22-004415

CIK 0001576885other

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 4:18 PM ET

Size

5.5 KB

Accession

0001209191-22-004415

Insider Transaction Report

Form 4
Period: 2022-01-19
Barton Russell
Chief Operating Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2022-01-19+135,000135,000 total
    Exercise: $5.19Exp: 2032-01-19Common Stock (135,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on January 19, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest and become exercisable each month thereafter, subject to Reporting Person continuing to provide service through each such date.

Issuer

Acumen Pharmaceuticals, Inc.

CIK 0001576885

Entity typeother

Related Parties

1
  • filerCIK 0001867418

Filing Metadata

Form type
4
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:18 PM ET
Size
5.5 KB